A pH-responsive nanoplatform with dual-modality imaging for enhanced cancer phototherapy and diagnosis of lung metastasis

Mujie Yuan,Zeyu Han,Yan Li,Xin Zhan,Yong Sun,Bin He,Yan Liang,Kui Luo,Fan Li,Kui Luo and Fan Li
DOI: https://doi.org/10.1186/s12951-024-02431-6
IF: 10.2
2024-04-15
Journal of Nanobiotechnology
Abstract:To address the limitations of traditional photothermal therapy (PTT)/ photodynamic therapy (PDT) and real-time cancer metastasis detection, a pH-responsive nanoplatform (NP) with dual-modality imaging capability was rationally designed. Herein, 1 H,1 H-undecafluorohexylamine (PFC), served as both an oxygen carrier and a 19 F magnetic resonance imaging (MRI) probe, and photosensitizer indocyanine green (ICG) were grafted onto the pH-responsive peptide hexahistidine (H 6 ) to form H 6 -PFC-ICG (HPI). Subsequently, the heat shock protein 90 inhibitor, gambogic acid (GA), was incorporated into hyaluronic acid (HA) modified HPI (HHPI), yielding the ultimate HHPI@GA NPs. Upon self-assembly, HHPI@GA NPs passively accumulated in tumor tissues, facilitating oxygen release and HA-mediated cell uptake. Once phagocytosed by lysosomes, protonation of H 6 was triggered due to the low pH, resulting in the release of GA. With near-infrared laser irradiation, GA-mediated decreased HSP90 expression and PFC-mediated increased ROS generation amplified the PTT/PDT effect of HHPI@GA, leading to excellent in vitro and in vivo anticancer efficacies. Additionally, the fluorescence and 19 F MRI dual-imaging capabilities of HHPI@GA NPs enabled effective real-time primary cancer and lung metastasis monitoring. This work offers a novel approach for enhanced cancer phototherapy, as well as precise cancer diagnosis.
biotechnology & applied microbiology,nanoscience & nanotechnology
What problem does this paper attempt to address?
This paper attempts to address the limitations of traditional photothermal therapy (PTT) and photodynamic therapy (PDT) in cancer treatment, as well as the problem of real - time monitoring of cancer metastasis. Specifically: 1. **Limitations of traditional photothermal therapy (PTT)**: - Over - expression of heat shock proteins (HSPs) induced by high temperature causes cancer cells to develop tolerance to photothermal therapy, thus affecting the treatment effect. 2. **Limitations of traditional photodynamic therapy (PDT)**: - The hypoxic characteristics of the tumor microenvironment (TME) lead to insufficient generation of reactive oxygen species (ROS), limiting the efficacy of photodynamic therapy. 3. **Monitoring problem of cancer metastasis**: - Although current methods have made certain progress in treating primary cancers, they are still insufficient in monitoring and treating cancers with metastatic tendencies. After successful treatment of the primary lesion, metastatic cancers may still gradually invade and endanger the patient's life. To solve the above problems, the authors designed a pH - responsive nanoplat form (NP) with dual - modal imaging capabilities (fluorescence imaging and 19F MRI) for enhancing cancer phototherapy and diagnosing lung metastases. The specific design is as follows: - **Material composition**: - **1H,1H - undecafluorohexylamine (PFC)**: As an oxygen carrier and 19F MRI probe. - **Indocyanine green (ICG)**: As a photosensitizer. - **Hexahistidine (H6)**: As a pH - responsive peptide. - **Curcuminic acid (GA)**: As a heat shock protein 90 (HSP90) inhibitor. - **Hyaluronic acid (HA)**: For modifying nanoparticles to achieve active targeting. - **Functional mechanism**: - **pH - responsive release**: Nanoparticles release GA through the protonation of H6 in the acidic tumor environment, inhibiting the expression of HSP90 and restoring the sensitivity of cancer cells to photothermal therapy. - **Oxygen supply**: PFC serves as an oxygen carrier, increasing the local oxygen concentration in tumor tissues and improving the effect of photodynamic therapy. - **Dual - modal imaging**: ICG is used for fluorescence imaging, and PFC is used for 19F MRI to achieve real - time monitoring of primary cancer and lung metastases. Through these designs, this nanoplat form not only enhances the anti - cancer effect of phototherapy but also provides the ability to monitor cancer progression in real - time, providing a new strategy for cancer treatment and diagnosis.